United States Biotechnology & Medical Research

NRX Pharmaceuticals Inc (NRXP)

Track

The most recent insider trading activity at NRX Pharmaceuticals Inc. occurred on December 17, 2024, when Chairman and Chief Scientist Jonathan C. Javitt purchased 40,000 shares. As this transaction took place more than three months ago, there has been no significant insider trading activity reported in the most recent quarter.
Ticker: NRXP Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 17 Dec 2024
Value US$1,505,918.61 | Price 403.37 | Shares 71,121 (+1.5%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-18 2024-12-17 B Purchase
Javitt Jonathan C

Chairman and Chief Scientist

Executive Director Large shareholder
71,121 +1.5%
403.37
US$1,505,919 		71,121 +1.5% 403.37 US$1,505,919
2023-09-11 2023-08-30 B Purchase
Gorovitz Aaron
Non-Executive Director
68,745 +17.1%
425.84
US$1,510,342 		68,745 +17.1% 425.84 US$1,510,342
2023-09-11 2023-08-30 B Purchase
Hurvitz Chaim
Non-Executive Director
30,628 -9.8%
106.88
US$119,595 		30,628 -9.8% 106.88 US$119,595
2023-08-24 2023-08-23 B Purchase
Javitt Jonathan C

Chief Scientist

Executive Director Large shareholder
100,000 +28.9%
0.33
US$33,000 		100,000 +28.9% 0.33 US$33,000
2023-08-23 2023-08-22 B Purchase
Javitt Jonathan C

Chief Scientist

Executive Director Large shareholder
200,000 +136.7%
0.32
US$64,400 		200,000 +136.7% 0.32 US$64,400
2022-12-19 2022-12-16 B Purchase
Willard Stephen H

CHIEF EXECUTIVE OFFICER

Executive Director
50,000 +inf%
1.17
US$58,500 		50,000 +inf% 1.17 US$58,500
2022-12-19 2022-12-16 B Purchase
VAN VOORHEES SETH

CHIEF FINANCIAL OFFICER

Officer
30,000 +183.6%
1.10
US$33,000 		30,000 +183.6% 1.10 US$33,000
2022-12-09 2022-12-07 S Sale
Javitt Jonathan C
Non-Executive Director Large shareholder
400,000 -3.0%
1.00
US$400,000 		400,000 -3.0% 1.00 US$400,000
2022-12-01 2022-11-30 PlS Planned sale
Javitt Daniel C.
Large shareholder
8,441 -0.1%
1.50
US$12,700 		8,441 -0.1% 1.50 US$12,700
2022-12-01 2022-11-29 PlS Planned sale
Javitt Daniel C.
Large shareholder
13,730 -0.1%
1.50
US$20,651 		13,730 -0.1% 1.50 US$20,651
2022-11-29 2022-11-28 B Purchase
Flynn Patrick John
Non-Executive Director
1,750 +inf%
1.25
US$2,188 		1,750 +inf% 1.25 US$2,188
2022-11-29 2022-11-28 B Purchase
Flynn Patrick John
Non-Executive Director
2,500 +6.6%
1.24
US$3,100 		2,500 +6.6% 1.24 US$3,100
2022-11-29 2022-11-28 B Purchase
Flynn Patrick John
Non-Executive Director
2,500 +7.1%
1.25
US$3,125 		2,500 +7.1% 1.25 US$3,125
2022-11-29 2022-11-28 B Purchase
Flynn Patrick John
Non-Executive Director
2,500 +6.6%
1.25
US$3,125 		2,500 +6.6% 1.25 US$3,125
2022-11-29 2022-11-28 B Purchase
Flynn Patrick John
Non-Executive Director
2,500 +7.1%
1.25
US$3,125 		2,500 +7.1% 1.25 US$3,125
2022-11-28 2022-11-25 B Purchase
VAN VOORHEES SETH

CHIEF FINANCIAL OFFICER

Officer
7,021 +75.0%
1.11
US$7,793 		7,021 +75.0% 1.11 US$7,793
2022-11-28 2022-11-25 B Purchase
VAN VOORHEES SETH

CHIEF FINANCIAL OFFICER

Officer
600 +6.9%
1.10
US$660 		600 +6.9% 1.10 US$660
2022-11-28 2022-11-25 B Purchase
VAN VOORHEES SETH

CHIEF FINANCIAL OFFICER

Officer
8,716 +inf%
1.12
US$9,762 		8,716 +inf% 1.12 US$9,762
2022-11-21 2022-11-18 B Purchase
Hurvitz Chaim
Non-Executive Director
40,408 +8.8%
1.10
US$44,449 		40,408 +8.8% 1.10 US$44,449
2022-11-21 2022-11-17 B Purchase
Hurvitz Chaim
Non-Executive Director
171,780 +59.7%
1.08
US$185,522 		171,780 +59.7% 1.08 US$185,522
2022-11-18 2022-11-17 PlS Planned sale
Javitt Daniel C.
Large shareholder
33,018 -0.3%
1.05
US$34,745 		33,018 -0.3% 1.05 US$34,745
2022-11-21 2022-11-16 B Purchase
Hurvitz Chaim
Non-Executive Director
287,812 +inf%
0.99
US$284,934 		287,812 +inf% 0.99 US$284,934
2022-11-18 2022-11-16 PlS Planned sale
Javitt Daniel C.
Large shareholder
133,719 -1.4%
1.02
US$136,393 		133,719 -1.4% 1.02 US$136,393
2022-11-15 2022-11-11 PlS Planned sale
Javitt Daniel C.
Large shareholder
49,200 -0.5%
1.01
US$49,510 		49,200 -0.5% 1.01 US$49,510
2022-08-02 2022-07-29 S Sale
Javitt Daniel C.
Large shareholder
784,063 -7.4%
1.01
US$791,433 		784,063 -7.4% 1.01 US$791,433
2022-06-07 2022-06-07 S Sale
Javitt Daniel C.
Large shareholder
86,459 -0.7%
0.65
US$55,861 		86,459 -0.7% 0.65 US$55,861
2022-06-07 2022-06-06 S Sale
Javitt Daniel C.
Large shareholder
115,657 -0.9%
0.67
US$76,947 		115,657 -0.9% 0.67 US$76,947
2022-06-07 2022-06-03 S Sale
Javitt Daniel C.
Large shareholder
243,596 -1.9%
0.70
US$171,102 		243,596 -1.9% 0.70 US$171,102
2022-06-02 2022-06-01 B Purchase
Javitt Jonathan C

Chief Scientist

Executive Director Large shareholder
100,000 +215.8%
58.00
US$5,800,000 		100,000 +215.8% 58.00 US$5,800,000
2021-11-02 2021-09-15 S Sale
Besthof Robert

Chief Comm. & Patient Officer

Officer
40,000 -62.8%
11.76
US$470,400 		40,000 -62.8% 11.76 US$470,400
2021-11-02 2021-08-23 S Sale
Daigneault Alessandra

General Counsel & Secretary

Officer
33,715 -100.0%
13.11
US$442,004 		33,715 -100.0% 13.11 US$442,004
2020-03-17 2020-03-13 S Sale
2.3
Polar Asset Management Partners Inc.
Large shareholder
29,464 -5.7%
10.60
US$312,318 		29,464 -5.7% 10.60 US$312,318
2018-11-20 2018-11-20 S Sale ACKERMAN RICHARD

President and CEO
1,500,000
0.00
US$0 		1,500,000 0.00 US$0
2017-12-04 2017-11-29 B Purchase ACKERMAN RICHARD

President and CEO
22,500 +9.0%
10.00
US$225,000 		22,500 +9.0% 10.00 US$225,000
Explore more

More insider trading research around NRX Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America